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ComplicationsAbstract Scope: Recently, many publicly funded healthcare organizations suffered from an eco-
nomical crisis. This forced some organizations to utilize less costly alternatives where possible. Insu-
lin cartridges and vials are examples. Many patients are questioning the difference between the two
alternatives as they contain the same active ingredient.
Objective: To ﬁnd out if insulin cartridges really provide a lower risk of potential diabetes
complications than traditional vials.
Method: A questionnaire was used to ask two random samples of diabetic patients about the
development of some diabetes complications. The ﬁrst sample (n= 41) consisted of patients using
cartridges; the second sample (n= 40) consisted of patients using vials. Patients were randomly
selected from the endocrine clinic and the out-patient pharmacy in Al-Hussein Hospital in King
Hussein Medical Center in Amman- Jordan.
Results: 44% of respondents in the ﬁrst sample did not suffer from any complication; on the
other hand, the percentage was only 15% of respondents in the second sample. All respondents
(100%) in the ﬁrst sample suffered from only 2 complications or less; however, 25% of the respon-
dents in the second sample suffered from 3 or more complications. Nephropathy complications,
were slightly higher in the ﬁrst sample; 22% compared to 15% in the second sample. On the other
Table 1 Demographics of the sam
First sample (cartridge) N= 41
Second sample (vial) N= 40
374 M.G. Al-Sharayri et al.hand, all complications reported in the second sample were higher; 30% for neuropathy, 65% for
retinopathy complications and 42.5% for extremities damage compared to only 9.7%, 7.3% and
26.8% respectively in the ﬁrst sample.
Conclusion: In general, respondents who were using cartridges reported a lesser incidence of
diabetes complications. Although many organizations suffered from an economical crisis, the
cost-effectiveness aspect should be taken into consideration when purchasing medical alternatives.
This will provide higher quality of life for patients and eventually lower hidden and future costs for
the organizations.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
In the last few years many publicly funded healthcare organi-
zations suffered from a ﬁnancial crisis due to the global eco-
nomical crisis. This forced some organizations to cut the
spending in different areas and to utilize less costly alternatives
where possible.
Although many studies showed that insulin cartridges are
more cost-effective than traditional vials; cartridges are much
more expensive (Al-Sharayri et al., 2013). Due to that, and un-
der the extreme budget limitations, many publicly funded
healthcare organizations decided to stabilize the purchase of
insulin cartridges and afford the cheaper alternative, the tradi-
tional vials, for new patients, at least for the meantime.
Many patients and even many healthcare professionals are
questioning the difference between the two alternatives, partic-
ularly when they know that both alternatives contain the same
active ingredient and are assumed to produce the same clinical
effect.
It is proven that insulin cartridges provide more accurate
dosing, less pain due to smaller needle gauge, increased social
acceptability and better quality of life (Bohannon, 1999). More
importantly, cartridges are assumed to improve patient adher-
ence (Baser et al., 2010).
Not far from all comparisons between the two alternatives,
this study is an attempt to give an answer to the following
question: do insulin cartridges really provide a lower risk of
potential diabetes complications than traditional vials?2. Methods
A questionnaire was used to ask two random samples of dia-
betic patients about the development of some diabetes compli-
cations. The ﬁrst sample (n= 41) consisted of patients using
cartridges; the second sample (n= 40) consisted of patients
using vials. Patients were randomly selected from the
endocrine clinic and the out-patient pharmacy in Al-Hussein
Hospital in King Hussein Medical Center in Amman- Jordan.
Respondents freely volunteered to ﬁll the questionnaire,
which consisted of one page. The respondents were asked to
draw a tick or a cross opposite to the suitable condition orples.
Age range A
22–72 44
22–70 48response. The data collected consisted of patient personal data,
history of diabetes (the time when ﬁrst diagnosed and the dura-
tion of insulin therapy), the presence of complications and its
type (neuropathy, retinopathy, nephropathy, and extremity
damages) and the presence of other chronic diseases (cardio-
vascular diseases, pulmonary diseases or other chronic
diseases).
3. Results
Table 1 shows the demographics of the respondents. Age
ranges of both samples were almost similar; however, the ﬁrst
sample was younger by nearly 4.5 years than the second sam-
ple. In both samples, males constituted a slight majority of the
respondents. Almost half of the respondents in the ﬁrst sample
and two thirds of the second sample suffered from another
chronic disease.
Table 2 shows the duration of the disease from the time
when ﬁrst diagnosed and the duration of insulin therapy for
both groups categorized by time intervals. About 73% of
respondents in the ﬁrst sample were diagnosed before 5 years
or more at the time of ﬁlling the questionnaire; the percentage
was 70% in the second sample.
The type of complications and their frequencies among the
respondents in both samples are shown in Table 3. It should be
mentioned that all the respondents in the ﬁrst sample suffered
from only 1 or 2 complications. In other words, there were no
respondents suffering from 3 or 4 complications; however, 10
respondents (25%) in the second sample suffered from 3 or
more complications. More importantly, there were 18 respon-
dents (44%) in the ﬁrst sample who did not suffer from any
complication; on the other hand, the number was only 6
respondents (15%) in the second sample.
4. Discussion
In this study, we measured the prevalence of diabetes compli-
cations among diabetic patients by using a questionnaire to eli-
cit data directly from the respondents. Both samples, in this
study, seemed to be almost similar i.e. age range, average
age and percentage of males in both samples were close; how-verage age (SD) Male (%) Other diseases
.27 (12.00) 25 (61%) 21 (51%)
.98 (13.18) 22 (55%) 27 (67%)
Table 3 Type and frequency of complications for both
samples.
Diabetic
complication
First sample
(N= 41)
Second sample
(N= 40)
Neuropathy 4 (9.7%) 12 (30%)
Retinopathy 3 (7.3%) 26 (65%)
Nephropathy 9 (21.9%) 6 (15%)
Extremities damage 11 (26.8%) 17 (42.5%)
No complications 18 (43.9%) 6 (15%)
Table 2 The duration of disease and insulin therapy for the respondents.
Less than 1 year 1–2 years 3–4 years 5 years or more
First sample N= 41 Time when ﬁrst diagnosed n= 1 n= 4 n= 6 n= 30
Duration of insulin therapy n= 2 n= 11 n= 14 n= 14
Second sample N= 40 Time when ﬁrst diagnosed n= 4 n= 0 n= 8 n= 28
Duration of insulin therapy n= 6 n= 5 n= 10 n= 19
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smaller number of chronic diseases.
Moreover, 73% of the respondents in the ﬁrst sample and
70% in the second sample were ﬁrst diagnosed as diabetic pa-
tients for more than 5 years. However, respondents in both
samples were using insulin therapy for different durations,
for instance, 5% of the ﬁrst sample and 15% of the second
sample were using insulin for 1 year or less. In other words,
the larger percentages of respondents were using insulin for a
long duration that is enough to give its desired outcome.
Apart from nephropathy, Table 3 shows that respondents
in the ﬁrst sample reported a much lesser incidence of diabetes
complications. In the case of nephropathy, the incidence was
slightly higher in the ﬁrst sample; it was about 22% in the ﬁrst
sample compared to 15% in the second sample. On the other
hand, respondents in the second sample reported 30% of neu-
ropathy complications, 65% of retinopathy complications and
42.5% of extremities damage compared to 9.7%, 7.3% and
26.8% respectively in the ﬁrst sample.
One of the study limitations is the presence of other chronic
diseases that could cause the same complication of diabetes.
For example, hypertension plays an important role along with
diabetes to cause nephropathy. This could contribute to the
above results.
The number of complications per respondent found in the
ﬁrst sample was lower. In other words, respondents with com-
plications, in the ﬁrst sample, suffered from lower number of
complications. There were no respondents in the ﬁrst sample
who suffered from 3 or more complications; however, 25%
of the respondents in the second sample suffered from 3 or
more complications.The other important result is the percentage of participants
that were free of any complications. Only 15% of respondents
in the second sample did not suffer from any complication;
however, 44% of the respondents in the ﬁrst sample reported
no complication. These results apparently agree with the
assumption that insulin cartridges may possibly provide lower
incidence of diabetes complications.
The ease of use and accuracy of dosing could be the most
important source of superiority of the cartridges over the vials
in producing lower incidence of diabetes complications. Ease
of use might be the motive behind increasing patient adher-
ence. Accuracy of dosing is a main issue that provides an ade-
quate control of blood sugar levels. Consequently, these
factors collectively may provide good management of the dis-
ease and prevent or delay the occurrence of the complications.
This will, eventually, provide a higher quality of life for pa-
tients and lower hidden and future costs for the organizations.
5. Conclusion
Generally, respondents who were using cartridges reported a
lesser incidence of diabetes complications. While the direct cost
of insulin cartridges is higher than vials, lower incidence of
complications will grant higher quality of life for patients
and ultimately lower costs for the organizations. The results
in this study, in fact, are supporting the international trends
in this ﬁeld.
Although many publicly funded healthcare organizations
suffered, recently, from an economical crisis which affected
the choices of purchasing medical alternatives, the cost-effec-
tiveness aspect should be taken into consideration.
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